We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Review of the evidence on the use and harms of xylazine, medetomidine and detomidine.
1. Introduction 1.1. Xylazine is a non-opioid tranquilizer approved for…
ACMD Chair: Prof Owen Bowden-Jones NPS Committee Secretary: Yetunde…
The home of Advisory Council on the Misuse of Drugs on GOV.UK. The Advisory Council on the Misuse of Drugs makes recommendations to government on the control of dangerous or otherwise harmful drugs, including classification …
The Advisory Council's report states that Ketamine should be controlled under the Misuse of Drugs Act 1971.
ACMD work programme 2024 letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs (ACMD).
Ketamine should be upgraded to a Class B drug following increased evidence of bladder damage from frequent misuse, experts have recommended.
Safe housing key to tackling homeless drug misuse, says ACMD.
The Advisory Council on the Misuse of Drugs (ACMD) seeks to gather insight into current government-led drug prevention policies and landscape across the UK.
The Advisory Council on the Misuse of Drugs makes recommendations to government on the control of dangerous or otherwise harmful drugs, including classification and scheduling under the Misuse of Drugs Act 1971 and its regul…
Recommendations from the ACMD to reduce barriers to research for schedule 1 controlled drugs.
Report of the findings of the ACMD's inquiry on children of problem drug users in the UK.
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
Details of the council's committees and latest meeting minutes.
A document developed by the Advisory Council on the Misuse of Drugs (ACMD) to outline the governing process for preparing evidence-based advice.
A lethal psychedelic drug should be controlled as a Class A substance, according to the Advisory Council on the Misuse of Drugs (ACMD).
The Advisory Council on the Misuse of Drugs call for evidence, collecting written evidence to better understand internet-facilitated drug markets (IFDMs).
This report advises government on the number and nature of known fentanyl analogues, risk factors, pharmacology, toxic effects and misuse and associated harms.
The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to review the harms of Xylazine and 2-Methyl-AP-237.
ACMD report providing advice to the government on the factors that make the homeless population vulnerable to substance misuse harms and how these can reduced.
Call for evidence from the Advisory Council on the Misuse of Drugs on the prevalence and drivers of powder cocaine use by young people and adults.
This report provides an updated assessment of the health and social harms of nitrous oxide.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.